Study: Real-World Results of GLP-1 Drugs Don't Match Trials

Health is not a matter of instant gratification

In a time where almost anything you could want is just a tap away—AI-powered answers in seconds, groceries delivered within the hour, endless content streamed instantly, and real-time validation through likes and shares—it’s no surprise that we’ve come to expect that same level of immediacy from our health. GLP-1 drugs promise rapid weight loss. Telemedicine provides patient care from the comfort of your own couch. At-home diagnostic tests deliv…

Study: Real-world results of GLP-1 drugs don't match trials

Real-world results for blockbuster weight-loss meds like Ozempic, Wegovy and Zepbound aren't as impressive as those promised by the drugs' clinical trials, a new study says.

Real-World Results For GLP-1 Drugs Underwhelm, Study Says

Key Takeaways

Should AMA 'Support' a Registry to Track Side Effects of GLP-1 Drugs?

(MedPage Today) -- CHICAGO -- Physicians debated the idea of the American Medical Association (AMA) supporting a registry to track adverse events tied to blockbuster diabetes and weight-loss medications during an open forum at the AMA's annual...

Have sky-high sales projections set the obesity market up to fail?

Market expectations for GLP-1 agonists have been high for some time. But in the past year, sales forecasts have gone stratospheric. Last month, Morgan Stanley Research upped its 2035 peak estimate for the obesity drug ...